Trial Profile
Safety of dapagliflozin in patients with type 2 diabetes: A retrospective cohort study from THIN database
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 05 Apr 2017
Price :
$35
*
At a glance
- Drugs Dapagliflozin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Adverse reactions
- 05 Apr 2017 New trial record
- 20 Feb 2017 Results published in the Journal of Clinical Endocrinology and Metabolism